SkyOak Wealth’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,520
Closed -$8.97K 267
2024
Q2
$8.97K Sell
14,520
-16,821
-54% -$14.2K ﹤0.01% 242
2024
Q1
$80.5K Sell
31,341
-5,299
-14% -$12.9K 0.02% 238
2023
Q4
$74.7K Sell
36,640
-24,235
-40% -$44.2K 0.02% 230
2023
Q3
$105K Sell
60,875
-13,420
-18% -$23.8K 0.03% 222
2023
Q2
$145K Sell
74,295
-52,413
-41% -$123K 0.04% 223
2023
Q1
$352K Sell
126,708
-2,580
-2% -$7.37K 0.11% 149
2022
Q4
$446K Sell
129,288
-3,563
-3% -$10.2K 0.15% 120
2022
Q3
$341K Hold
132,851
0.12% 138
2022
Q2
$321K Sell
132,851
-36,885
-22% -$96.9K 0.11% 148
2022
Q1
$699K Buy
169,736
+143,156
+539% +$758K 0.19% 104
2021
Q4
$342K Buy
26,580
+56
+0.2% +$620 0.09% 171
2021
Q3
$286K Hold
26,524
0.08% 183
2021
Q2
$242K Sell
26,524
-889
-3% -$8.22K 0.06% 196
2021
Q1
$268K Sell
27,413
-42,365
-61% -$583K 0.07% 182
2020
Q4
$275K Buy
+69,778
New +$211K 0.09% 172

Other funds holding GRTS

SkyOak Wealth's GRTS Position: Q3 2024 in Review

SkyOak Wealth sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 14,520 shares — an estimated $8.97K sold.

SkyOak Wealth first reported a position in GRTS in Q4 2020 and held it in 15 quarters. The position peaked at $699K in Q1 2022. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • SkyOak Wealth reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • SkyOak Wealth sold 14,520 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $8.97K.
  • SkyOak Wealth first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 15 quarters.
  • SkyOak Wealth's Gritstone bio, Inc. Common Stock position peaked at $699K in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on SkyOak Wealth's 13F filing for Q3 2024, filed 4 Nov 2024.